[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"monitoring\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:monitoring":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,42,66,90,119,147,167,194,220],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":4},"100645192","non-contact-patient-monitoring-with-millimeter-wave-radar-technology-100645192",false,"NCT07677735","Non-contact Patient Monitoring With Millimeter Wave Radar Technology.","Development of a Contactless Patient Monitoring System Using Millimeter Wave Radar Technology","Inclusion Criteria:\n\n* Participating in the research as a researcher\n\nExclusion Criteria:\n\n* Wanting to withdraw from the research",true,"ALL","18 Years",{"count":20,"type":21},6,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study aims to develop a millimeter wave radar technology-based patient monitoring system that allows for the monitoring of physiological and movement-based data in healthcare settings without requiring physical contact with individuals. The study will involve the creation of hardware and software components for processing, analyzing, and converting signals obtained through radar sensors into clinically meaningful data.",[27,28,29],"Radar","Monitoring","Physiologic Monitoring","NOT_YET_RECRUITING","2026-06-25",{"date":33,"type":34},"2026-07-01","ACTUAL",{"date":36,"type":21},"2026-08-01",{"date":38,"type":21},"2026-10-01",{"name":40,"class":41},"Rukiye Kokkiz","OTHER",{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":22,"phases":50,"briefSummary":51,"conditions":52,"keywords":53,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":65},"100616761","portrait-mobile-monitoring-solution-v20-external-evaluation-100616761","NCT07309809","Portrait Mobile Monitoring Solution V2.0 External Evaluation","Inclusion Criteria:\n\n1. Participant is age 18 years or older (≥18 years).\n2. Participant must have the ability to understand and provide written informed consent.\n3. Are being cared for in a hospital unit and are expected to remain in the unit for the duration of the study procedure.\n4. Participant must be willing and able to comply with study procedures and duration.\n\nExclusion Criteria:\n\n1. Known to be pregnant and\u002For breast feeding.\n2. Diagnosed with infection requiring isolation.\n3. Are immunocompromised.\n4. Have previously participated in this study (no subject may participate more than once).\n5. Subjects with Implantable Minute Ventilation Rate Responsive Pacemakers should be excluded from respiration rate monitoring.",{"count":49,"type":21},50,[24],"The purpose of this study is to collect and assess feedback from the users regarding the functionality and performance of the Portrait Mobile Monitoring Solution V2.0. In addition, this study aims to collect raw parameter data from the investigational devices for use in current and future Portrait Mobile development, including engineering purposes as deemed appropriate by the Sponsor.",[28],[54],"Continuous Monitoring","2026-06-08",{"date":57,"type":34},"2026-06-10",{"date":59,"type":21},"2026-07",{"date":61,"type":21},"2026-10",{"name":63,"class":64},"GE Healthcare","INDUSTRY",1,{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":73,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":76,"conditions":77,"keywords":4,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":65},"100638477","esotip-tee-defining-an-easy-landmark-to-guide-correct-esophageal-probe-placement-with-transesophageal-echocardiography-100638477","NCT07574736","ESOTIP-TEE: Defining an Easy Landmark to Guide Correct Esophageal Probe Placement With Transesophageal Echocardiography","ESOTIP-TEE","Inclusion Criteria:\n\n* Adult (≥18 years) patients admitted to the ICU\n* Clinical indication to perform a transesophageal echocardiography\n\nExclusion Criteria:\n\n* \\\u003C18 years",{"count":74,"type":21},30,"OBSERVATIONAL","This prospective observational study aims to identify simple external anatomical landmarks that allow reliable prediction of correct esophageal probe insertion depth. Accurate placement in the lower third of the esophagus is essential for reliable core temperature monitoring. Transesophageal echocardiography (TEE) will be used as the reference standard to confirm correct probe position. The study will evaluate the agreement between landmark-based insertion depth and TEE-confirmed placement in adult ICU patients undergoing clinically indicated TEE.",[28,78,79],"Esophageal Temperature","Hypothermia","RECRUITING","2026-05-05",{"date":83,"type":34},"2026-05-08",{"date":85,"type":34},"2025-12-12",{"date":87,"type":21},"2026-07-30",{"name":89,"class":41},"Institute of Mountain Emergency Medicine",{"id":91,"slug":92,"hasResults":11,"nctId":93,"briefTitle":94,"officialTitle":95,"acronym":96,"eligibilityCriteria":97,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":98,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":100,"conditions":101,"keywords":105,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":118},"100635619","correlation-between-capillary-refill-time-and-perfusion-index-in-critically-ill-patients-100635619","NCT07555041","Correlation Between Capillary Refill Time and Perfusion Index in Critically Ill Patients","Correlation Between Capillary Refilling tIme and Perfusion Index in Critically Ill Patients","CRIPI","Inclusion criteria :\n\n* Adult patient.\n* Admission within the previous 24 hours, or within 24 hours of the onset of a hemodynamic instability criterion (requirement for vasopressors or fluid resuscitation).\n* Absence of patient objection.\n\nExclusion criteria :\n\n* Legal guardianship, curatorship, or judicial protection.\n* No social security coverage.\n* Morphological abnormalities preventing CRT and IP measurements.",{"count":99,"type":21},250,"Assessment of capillary refill time (CRT) is a cornerstone of tissue perfusion monitoring in critically ill patients.\n\nCRT measurement is performed by applying brief and gentle pressure (for a few seconds) to a small area of skin until blanching occurs. CRT is defined as the time, in seconds, required for the skin surface to return to its initial color after release of pressure.\n\nAlthough CRT is a monitoring tool used on a daily basis in emergency departments and critical care units, its practical measurement modalities remain poorly standardized and time-consuming. Consequently, there is no consensus regarding the most reproducible bedside method for CRT assessment. Moreover, repeated CRT measurements during patient management are resource-intensive in terms of medical time and may raise issues related to healthcare staff availability.\n\nThe perfusion index (PI) is a marker of tissue perfusion derived from a pulse oximetry sensor. This monitoring device is routinely used in all critically ill patients. It is placed on the finger and worn continuously, including during patient transport.\n\nBecause PI measurement is automatic and continuous, establishing its correlation with CRT could allow for more precise tissue perfusion monitoring while reducing the time burden associated with bedside assessments in critically ill patients.",[102,103,104,28],"Shock State","Hemodynamics Instability","Microcirculation",[106,107,104,108],"Capillary refill time","Perfusion index","Intensive care","2026-04-30",{"date":111,"type":34},"2026-05-01",{"date":113,"type":34},"2026-04-29",{"date":115,"type":21},"2027-05-29",{"name":117,"class":41},"Hospices Civils de Lyon",2,{"id":120,"slug":121,"hasResults":11,"nctId":122,"briefTitle":123,"officialTitle":124,"acronym":125,"eligibilityCriteria":126,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":127,"enrollmentInfo":128,"targetDuration":130,"studyType":75,"phases":4,"briefSummary":131,"conditions":132,"keywords":134,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":138,"lastUpdatePostDateStruct":139,"startDateStruct":141,"completionDateStruct":143,"leadSponsor":145,"locationsCount":118},"100597659","the-use-of-the-bambi-belt-in-exteremly-preterm-infants-an-implementation-study-100597659","NCT07061366","The Use of the Bambi-Belt in Exteremly Preterm Infants: an Implementation Study.","The Use of the Bambi-Belt in Exteremly Preterm Infants: an Implementation Study","BB-EP","Inclusion Criteria: Preterm born \\\u003C26 weeks; first week of life -\n\nExclusion Criteria: skin integrity problems prior to study, palliative care.\n\n\\-","1 Week",{"count":129,"type":21},15,"1 Month","This observational, non-interventional cohort study evaluates the clinical use of the Bambi Belt-a CE-certified, wireless device for non-invasive heart rate and respiration monitoring-in extremely preterm infants (\\\u003C26 weeks gestation). 15 infants with intact skin and age \\\u003C24 hours will be monitored using the Bambi Belt during the first ten days of life. Primary outcomes include ease of use (application, signal stability), skin tolerance, and user experience (nurses and parents). Standard care remains unchanged. Data will be collected via clinical records and evaluation forms.",[133,28],"Preterm",[135,136,137],"wireless","monitoring","heart rate","2026-03-09",{"date":140,"type":34},"2026-03-11",{"date":142,"type":34},"2025-08-10",{"date":144,"type":21},"2027-01-01",{"name":146,"class":41},"Maxima Medical Center",{"id":148,"slug":149,"hasResults":11,"nctId":150,"briefTitle":151,"officialTitle":151,"acronym":4,"eligibilityCriteria":152,"healthyVolunteers":11,"sex":17,"minAge":153,"maxAge":4,"enrollmentInfo":154,"targetDuration":4,"studyType":22,"phases":155,"briefSummary":156,"conditions":157,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":161,"completionDateStruct":163,"leadSponsor":165,"locationsCount":4},"100601439","comparison-of-hemodynamic-variables-between-using-conventional-invasive-catheter-monitoring-and-non-invasive-piezoelectric-sensor-100601439","NCT07110506","Comparison of Hemodynamic Variables Between Using Conventional Invasive Catheter Monitoring and Non-invasive Piezoelectric Sensor","Inclusion Criteria:\n\n* Cases who require Invasive arterial pressure monitoring d\u002Ft bleeding.\n\nExclusion Criteria:\n\n* Patients with cardiovascular disease, cerebrovascular diseases, renal disease, or Marfan syndrome\n* Pregnancy","19 Years",{"count":74,"type":21},[24],"Arterial pressure is obtained from invasive arterial monitoring and noninvasive arterial monitoring using piezoelectric sensor and compared.",[28],"2025-07-31",{"date":160,"type":34},"2025-08-07",{"date":162,"type":21},"2025-08-22",{"date":164,"type":21},"2026-12-18",{"name":166,"class":41},"SMG-SNU Boramae Medical Center",{"id":168,"slug":169,"hasResults":11,"nctId":170,"briefTitle":171,"officialTitle":172,"acronym":173,"eligibilityCriteria":174,"healthyVolunteers":16,"sex":175,"minAge":18,"maxAge":4,"enrollmentInfo":176,"targetDuration":4,"studyType":22,"phases":177,"briefSummary":178,"conditions":179,"keywords":181,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":186,"lastUpdatePostDateStruct":187,"startDateStruct":189,"completionDateStruct":191,"leadSponsor":193,"locationsCount":4},"100598870","feasibility-study-continuous-fetal-monitoring-during-maternal-exercise-100598870","NCT07077109","Feasibility Study: Continuous Fetal Monitoring During Maternal Exercise","Continuous Non-invasive Electrophysiological Monitoring During Maternal Exercise: a Feasibility Study","NIEM-S","Inclusion Criteria:\n\n* Minimal age of 18 years old\n* Pregnant women with an uncomplicated singleton pregnancy and a gestational age between 30+0 and 40+0 weeks and days\n* Oral and written informed consent is obtained\n* Engage in aerobic exercise during pregnancy\n\nA potential subject who meets any of the following criteria will be excluded from participation in this study:\n\n* Insufficient knowledge of Dutch or English language\n* Women with a multiple pregnancy\n* Contra-indications for the Nemo Fetal Monitoring System (NFMS):\n\n  * Fetal and\u002For maternal cardiac arrhythmias\n  * Contraindications to abdominal placement (dermatologic diseases of the abdomen precluding preparation of the abdomen with abrasive paper)\n  * Women connected to an external or implanted electrical stimulator, such as a pacemaker (because of disturbance of the electrophysiological signal)\n* Fetus with known congenital or chromosomal abnormalities\n* Women with absolute or relative contraindications to aerobic exercise during pregnancy at time of inclusions and during maternal exercise:\n\n  * Mild or severe respiratory diseases (e.g. chronic obstructive pulmonary disease, restrictive lung disease and cystic fibrosis)\n  * Mild or severe acquired or congenital heart disease with exercise intolerance\n  * Uncontrolled or severe arrhythmia\n  * Vasa previa\n  * Type 1 diabetes\n  * IUGR\n  * Severe PE\n  * Cervical insufficiency\n* Women with relative contraindications to aerobic exercise during pregnancy:\n\n  * Mild respiratory disorders\n  * Mild congenital or acquired heart disease\n  * Well-controlled type 1 diabetes\n  * Pre-eclampsia\n  * Cervical insufficiency\n  * Placenta previa\n  * Untreated thyroid disease\n  * Symptomatic, severe eating disorder\n  * Multiple nutrient deficiencies and\u002For chronic undernutrition\n  * Moderate-heavy smoking (\\> 20 cigarettes per day)","FEMALE",{"count":129,"type":21},[24],"This feasibility study will be the first study to assess the feasibility of continuous electrophysiological monitoring during maternal exercise in women with an uncomplicated pregnancy. This may help to better understand fetal condition during exercise and offer personalised exercise recommendations in the future. In future, validating the feasibility and safety of exercise could promote greater exercise engagement among pregnant women and increase fetal wellbeiing.",[180,28],"Pregnancy",[182,180,183,184,185],"Electrophysiological monitoring","Sport","Feasibility study","Maternal exercise","2025-07-23",{"date":188,"type":34},"2025-07-28",{"date":190,"type":21},"2025-10-15",{"date":192,"type":21},"2026-03-13",{"name":146,"class":41},{"id":195,"slug":196,"hasResults":11,"nctId":197,"briefTitle":198,"officialTitle":198,"acronym":199,"eligibilityCriteria":200,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":201,"enrollmentInfo":202,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":204,"conditions":205,"keywords":208,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":211,"lastUpdatePostDateStruct":212,"startDateStruct":214,"completionDateStruct":216,"leadSponsor":218,"locationsCount":65},"100555416","correlation-between-noninvasive-blood-vessel-functionality-parameters-and-cerebral-hemodynamics-in-neurocritical-care-patients-100555416","NCT06511804","Correlation Between Noninvasive Blood Vessel Functionality Parameters and Cerebral Hemodynamics in Neurocritical Care Patients","Mespere ICP","Inclusion Criteria:\n\nSubjects who meet all the following inclusion criteria may be included:\n\n1. Adults (\\> 18 years of age);\n2. Able and willing to provide written informed consent for participation by self or legally authorized representatives.\n3. Clinical diagnosis of traumatic brain injury (TBI), brain hemorrhage, brain tumor, neurotrauma (including closed head injuries, penetrating head injuries, or other forms of neurotrauma), hemorrhage (intracerebral or subarachnoid), or stroke.\n4. Continuous Blood Pressure Monitoring: Patients must have continuous blood pressure monitoring in place during the study period, obtained from an arterial line. This criterion ensures that we have real-time data on mean arterial pressure (MAP) and systolic pressure (SBP).\n5. Intracranial Pressure (ICP) Monitoring: Patients must have intracranial pressure (ICP) monitoring in place during the study period. This criterion ensures that we can assess the correlation between our blood vessel functionality parameters (VDC, VR, and VRx) and ICP, a key indicator of intracranial dynamics.\n\nExclusion Criteria:\n\n1. Subjects who meet any of the following exclusion criteria will be excluded:\n2. Expected to be at increased risk due to study participation (e.g. due to hemodynamic instability), in the medical opinion of an investigator;\n3. Pregnant as determined per site standard practice;\n4. Previously participated in this study, or are enrolled in another research study that could be expected to interfere with participation, in the opinion of the investigator;\n5. Require or are anticipated to require emergent medical care in which study participation may reasonably delay his\u002Fher medical care or increase risk or unfavorable outcome, in the opinion of the investigator;\n6. Allergy to adhesive tape;\n7. Ongoing photodynamic therapy.","100 Years",{"count":203,"type":21},25,"The purpose of this clinical research project is to employ Mespere LifeSciences NeurOs Cerebral Oximetry system, equipped with noninvasive sensors approved by the FDA, to monitor and investigate the correlation within a cohort of patients suffering from traumatic brain injury (TBI), stroke, brain tumor, and brain bleeding. This study aims to investigate and establish the correlation between blood vessel functionality parameters-specifically, Vasodilation\u002FConstriction Index (VDC), Vascular Resistance Index (VR), and Volume Reactivity Index (VRx)-with the crucial physiological indicators, Intracranial Pressure (ICP) and Mean Arterial Pressure (MAP). By doing so, the investigators seek to address fundamental questions surrounding cerebral hemodynamics and autoregulation in various neurological conditions.",[206,207,28],"Brain Injuries","Intracranial Pressure Increase",[209,136,210],"intracranial pressure","noninvasive","2025-05-26",{"date":213,"type":34},"2025-05-30",{"date":215,"type":34},"2024-11-17",{"date":217,"type":21},"2026-06-30",{"name":219,"class":41},"University of Louisville",{"id":221,"slug":222,"hasResults":11,"nctId":223,"briefTitle":224,"officialTitle":224,"acronym":4,"eligibilityCriteria":225,"healthyVolunteers":11,"sex":17,"minAge":130,"maxAge":226,"enrollmentInfo":227,"targetDuration":4,"studyType":75,"phases":4,"briefSummary":229,"conditions":230,"keywords":4,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":233,"lastUpdatePostDateStruct":234,"startDateStruct":236,"completionDateStruct":238,"leadSponsor":240,"locationsCount":65},"100318502","correlation-between-sedation-depth-monitoring-and-reflexes-during-intravenous-anesthesia-with-dexmedetomidine-and-remifentanil-in-children-undergoing-direct-laryngoscopy-for-surgical-procedures-100318502","NCT03426579","Correlation Between Sedation Depth Monitoring and Reflexes During Intravenous Anesthesia With Dexmedetomidine and Remifentanil in Children Undergoing Direct Laryngoscopy for Surgical Procedures","Inclusion Criteria:\n\nscheduled for elective direct laryngoscopy with surgical intervention, written informed consent of their parents or legal guardian.\n\nExclusion Criteria:\n\nrefusal of informed consent, known allergy for dexmedetomidine or remifentanil at start of anesthesia pulse oxygen saturation (SaO2) lower than 85%","8 Years",{"count":228,"type":21},10,"This study evaluates the correlation between sedation depth monitoring obtained by NeuroSENSE ® NS 701 Monitor and reflexes during intravenous anesthesia in children undergoing direct laryngoscopy for surgical procedures.",[231,232,28],"Laryngoscopy","Child","2025-01-20",{"date":235,"type":34},"2025-01-22",{"date":237,"type":34},"2017-10-23",{"date":239,"type":21},"2025-12-31",{"name":241,"class":41},"University Hospital, Antwerp"]